Prelude Therapeutics
PRLD
PRLD
70 hedge funds and large institutions have $74M invested in Prelude Therapeutics in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
5% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 21
43% less capital invested
Capital invested by funds: $129M → $74M (-$55.2M)
Holders
70
Holding in Top 10
–
Calls
$1K
Puts
$1K
Top Buyers
| 1 | +$1.91M | |
| 2 | +$1.84M | |
| 3 | +$743K | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$583K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$427K |
Top Sellers
| 1 | -$1.78M | |
| 2 | -$1.22M | |
| 3 | -$759K | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$134K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$71.8K |